Browse Papers

Search the literature by keyword, topic, or author. Filter to articles with full text available.

3689 results

Full text 2026

Safety and efficacy of a feed additive consisting of l-histidine monohydrochloride monohydrate produced with <i>Escherichia coli</i>CCTCC M 20241089 for all animal species (Anhui Huaheng Biotechnology Co., Ltd)

EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, et al.

Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of l-histidine monohydrochloride monohydrate produced with a genetically modified strain of <i>Escherichia coli</i> (CCTCC M …

Read PDF
Bioinformatics
Full text 2026

Causal association and molecular mechanisms of periodontal disease and muscle wasting and atrophy: Mendelian randomization and bioinformatics analysis

Liu Y, Zhang W, Liu Y, et al.

<h4>Background</h4>Periodontal disease, a chronic inflammatory disorder, is increasingly linked to systemic conditions. This study investigates its causal role in muscle wasting via chronic inflammation, aiming to inform integrative therapeutic strategies.<h4>Methods</h4>Mendelian randomization (MR) analysis was applied …

Read PDF
Bioinformatics
Full text 2026

Artificial intelligence for antimicrobial resistance: advancing reproducibility, interpretability, and clinical deployment

Sardar S, Dash S, Roychowdhury P, et al.

The shift of artificial intelligence for antimicrobial resistance (AI-AMR) from proof-of-concept studies to clinically embedded decision support critically hinges on establishing rigorous reproducibility, interpretability, and evaluation standards aligned with antimicrobial stewardship and patient safety. This …

Read PDF
Bioinformatics
Full text 2026

Unlocking therapeutic impacts of the gut microbiota with computational tools

Kharb A, Zhu X.

The human gut microbiota, particularly the intestinal microbiota, shapes host physiology, disease risk, and therapeutic outcomes through complex metabolic and enzymatic activities. Recent advances in molecular omics, metabolomics, enzyme bioinformatics, and artificial intelligence (AI) have …

Read PDF
Bioinformatics Metagenomics
Full text 2026

Evaluation of PD-L1 Expression and Systemic Inflammatory Blood Cell Ratios as Prognosticators in Advanced Lung, Breast and Head and Neck Cancers

Nedjadi T, AlBoraie S, Alghamdi W, et al.

<h4>Introduction</h4>Immunotherapy with immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis has become an established treatment strategy across various malignancies. In this context, PD-L1 expression plays a key role in the clinical management of cancer patients. …

Read PDF
Bioinformatics
Full text 2025

Target and biomarker exploration portal for drug discovery

Dewangan B, Ray D, Ren Y, et al.

<h4>Motivation</h4>The discovery of novel drug targets and precision biomarkers remains a major challenge in drug development, with traditional differential expression analysis often overlooking key regulatory proteins. Here, we present a novel, web-based bioinformatics tool, the …

Read PDF
Bioinformatics